Skip to main content
Erschienen in: Indian Journal of Surgery 4/2016

12.11.2015 | Original Article

Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma

verfasst von: Mihaela Vlad, Ioana Zosin, Bogdan Timar, Fulger Lazar, Adrian Vlad, Romulus Timar, Marioara Cornianu

Erschienen in: Indian Journal of Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Medullary thyroid carcinoma (MTC) is a rare form of malignancy, having an intermediate prognosis. Controversies exist regarding the best surgical approach. The aim of the study was to analyze the outcome in a group of patients with MTC, diagnosed and followed up in a single care center. We performed a retrospective analysis of all the patients diagnosed with MTC in the Department of Endocrinology from the County Emergency Hospital Timisoara between 1992 and 2012. The study group included 19 patients, 6 men (31.6 %), mean age 41.2 ± 12.5 years (20–72 years). The preoperative diagnosis was based on the protocol for nodular thyroid disease. Total or near-total thyroidectomy was performed in 10 out of 16 patients who could be operated. Postoperative follow-up included repeated measurements of serum calcitonin and imaging investigations. Nine out of the total of 19 (47.3 %) patients had hereditary forms of MTC. Most of the cases (84.2 %) were submitted to surgery. The median duration of follow-up was 84 months. The pTNM staging indicated that the majority of the patients with hereditary MTC were diagnosed in an earlier stage. Disease remission was achieved in 7 cases (43.8 %). Four patients, all with sporadic forms, died. Survival rates at 1, 5 and 10 years were significantly higher (p = 0.048) in patients with hereditary MTC. An early diagnosis of MTC allows a better surgical approach and an improved survival rate. We support the general recommendation that modified radical neck dissection is not necessary for all the patients with MTC.
Literatur
2.
Zurück zum Zitat Schlumberger MJ, Filetti S, Hay ID (2008) Nontoxic diffuse and nodular goiter and thyroid neoplasia. In: Kronenberg HM, Melmed S, Polonsky KS, Reed Larsen P (eds) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 411–442 Schlumberger MJ, Filetti S, Hay ID (2008) Nontoxic diffuse and nodular goiter and thyroid neoplasia. In: Kronenberg HM, Melmed S, Polonsky KS, Reed Larsen P (eds) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 411–442
3.
Zurück zum Zitat Grozinsky-Glasberg S, Benbassat CA, Tsvetov G, Feinmesser R, Hava Peretz H, Shimon I, Lapidot M (2007) Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. Thyroid 17:549–556CrossRefPubMed Grozinsky-Glasberg S, Benbassat CA, Tsvetov G, Feinmesser R, Hava Peretz H, Shimon I, Lapidot M (2007) Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. Thyroid 17:549–556CrossRefPubMed
4.
Zurück zum Zitat American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612. doi:10.1089/thy.2008.0403 CrossRef American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612. doi:10.​1089/​thy.​2008.​0403 CrossRef
5.
Zurück zum Zitat Schlumberger M, Bastholt L, Dralle H, Jarzab B, Pacini F, Smit JWA, The European Thyroid Association Task Force (2012) 2012 European Thyroid Association guidelines for metastatic medullary thyroid cancer. Eur Thyroid J 1:5–14. doi:10.1056/NEJMoa1108586 CrossRefPubMedCentral Schlumberger M, Bastholt L, Dralle H, Jarzab B, Pacini F, Smit JWA, The European Thyroid Association Task Force (2012) 2012 European Thyroid Association guidelines for metastatic medullary thyroid cancer. Eur Thyroid J 1:5–14. doi:10.​1056/​NEJMoa1108586 CrossRefPubMedCentral
7.
Zurück zum Zitat Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB (2003) Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery 134:890–899CrossRefPubMed Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB (2003) Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery 134:890–899CrossRefPubMed
8.
Zurück zum Zitat Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887CrossRefPubMedPubMedCentral Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245:604–610CrossRefPubMedPubMedCentral Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245:604–610CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Greene FL, Page DL, Fleming ID, Fritz A, Balch DM (2003) AJCC cancer staging manual, 6th edn. Springer Verlag, Chicago Greene FL, Page DL, Fleming ID, Fritz A, Balch DM (2003) AJCC cancer staging manual, 6th edn. Springer Verlag, Chicago
13.
Zurück zum Zitat Gülben K, Berberoğlu U, Boyabatli M (2006) Prognostic factors for sporadic medullary thyroid carcinoma. World J Surg 30:84–90CrossRefPubMed Gülben K, Berberoğlu U, Boyabatli M (2006) Prognostic factors for sporadic medullary thyroid carcinoma. World J Surg 30:84–90CrossRefPubMed
14.
Zurück zum Zitat Clark JR, Fridman TR, Odell MJ, Brierley J, Walfish PG, Freeman JL (2005) Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope 115:1445–1450CrossRefPubMed Clark JR, Fridman TR, Odell MJ, Brierley J, Walfish PG, Freeman JL (2005) Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope 115:1445–1450CrossRefPubMed
16.
Zurück zum Zitat Hyer SL, Vini L, A’Hern R, Harmer C (2000) Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol 26:686–690CrossRefPubMed Hyer SL, Vini L, A’Hern R, Harmer C (2000) Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol 26:686–690CrossRefPubMed
17.
Zurück zum Zitat Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L (1996) Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556–1565CrossRefPubMed Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L (1996) Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556–1565CrossRefPubMed
18.
Zurück zum Zitat Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148CrossRefPubMed Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148CrossRefPubMed
19.
Zurück zum Zitat Ito Y, Miyauchi A, Yabuta T, Fukushima M, Inoue H, Tomoda C, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg 33:58–66. doi:10.1007/s00268-008-9795-2 CrossRefPubMed Ito Y, Miyauchi A, Yabuta T, Fukushima M, Inoue H, Tomoda C, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg 33:58–66. doi:10.​1007/​s00268-008-9795-2 CrossRefPubMed
20.
Zurück zum Zitat de Groot JW, Plukker JT, Wolffenbuttel BH, Wiggers T, Sluiter WJ, Links TP (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clin Endocrinol (Oxf) 65:729–736CrossRef de Groot JW, Plukker JT, Wolffenbuttel BH, Wiggers T, Sluiter WJ, Links TP (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clin Endocrinol (Oxf) 65:729–736CrossRef
21.
Zurück zum Zitat O’Riordain DS, O’Brien T, Weaver AL, Gharib H, Hay ID, Grant CS, van Heerden JA (1994) Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery 116:1017–1023PubMed O’Riordain DS, O’Brien T, Weaver AL, Gharib H, Hay ID, Grant CS, van Heerden JA (1994) Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery 116:1017–1023PubMed
Metadaten
Titel
Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma
verfasst von
Mihaela Vlad
Ioana Zosin
Bogdan Timar
Fulger Lazar
Adrian Vlad
Romulus Timar
Marioara Cornianu
Publikationsdatum
12.11.2015
Verlag
Springer India
Erschienen in
Indian Journal of Surgery / Ausgabe 4/2016
Print ISSN: 0972-2068
Elektronische ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-015-1386-5

Weitere Artikel der Ausgabe 4/2016

Indian Journal of Surgery 4/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.